PPCOS-II
2014
Pregnancy in Polycystic Ovary Syndrome II
In 750 women with polycystic ovary syndrome and infertility, letrozole improved the cumulative live-birth rate compared with clomiphene.
Result
Efficacy: Cumulative live-birth rateRR 1.44 (95% CI 1.10-1.87) · P = 0.007
Below 1 favours clomiphene, above 1 favours letrozole.
- Absolute difference
- 8.4 points
- NNT
- 12
Absolute difference and NNT are derived from the event rates.
- Subtopic
- Ovulation induction in PCOS
- Design
- Double-blind RCT, up to 5 treatment cycles
- Relevance
- Important: one of several pillars.
- Source
- Legro RS, et al. N Engl J Med. 2014;371(2):119-129.doi 10.1056/NEJMoa1313517
Discussion & critique
Letrozole became first-line for ovulation induction in PCOS, still off-label in Germany but endorsed by reproductive-endocrinology guidance.